Research news

Find out about research study findings and developments

Join Dementia Research volunteers help discover Alzheimer’s drug lecanemab

1 December 2022

The findings of a research study that discovered a treatment for early stage Alzheimer’s disease have been hailed as “momentous” by Alzheimer’s Research UK.  The new treatment, lecanemab, is the first drug to slow cognitive decline in people with early signs of the condition. The CLARITY-AD study enrolled 1,795 patients with early-stage Alzheimer’s globally, including Join […]

Dementia during COVID-19 – the lived experience perspective

10 November 2022

A Scottish study which recruited participants through Join Dementia Research has published their findings on the effects of the adapted dementia diagnosis and consultation processes during the COVID-19 pandemic. The research has been co-produced by the University of Edinburgh and the Better Understanding Dementia Diagnosis (BUDDs) lived experience group, and funded by UK Research and […]

Lecanemab – a potential new treatment for Alzheimer’s disease

28 September 2022

News that a potential treatment for early stage Alzheimer’s disease can slow cognitive decline is a significant development in dementia research. About the drug Lecanemab is an antibody that is designed to remove toxic beta-amyloid deposits; proteins that build up in the brains of people with Alzheimer’s disease. Following phase 3 clinical trials, pharmaceutical companies […]

Global Brain Health Survey Findings

9 June 2022

Although the causes of dementia are not yet known, we do know which lifestyle choices such as diet, exercise and smoking can affect brain health and the chances of developing dementia. Until now, there has been little insight into the perceptions of brain health around the world. In June 2019 an anonymous online survey ‘The […]

Breakthrough Alzheimer’s drug approved in the US

8 June 2021

MRI brain scan images

The US Food and Drug Administration (FDA) has this week approved the first drug since 2003 to treat Alzheimer’s disease. Aducanumab, created by US pharmaceutical company Biogen, is an antibody designed to target amyloid, a protein that builds up in the brains of people with early stages of Alzheimer’s disease. Whereas other existing treatments help […]

Five tips to support people with dementia and carers while in lockdown

27 April 2020

Lockdown and social distancing are essential to help combat COVID-19, but adjusting can be difficult – especially for people living with dementia. That’s why researchers have developed a new leaflet with five simple tips, designed to help make things more manageable for anyone who currently lives with dementia or cares for someone who does. The leaflet gives practical and self-help tips on five key points, and has been created using the latest robust research with the input of people affected by dementia.

Dementia fears for former footballers

25 October 2019

Football on grass

A recent study has found that the risk of dying from neurodegenerative disease is almost 3.5 times higher for footballers. However research is at an early stage and there’s currently no suggestion that anyone should stop playing football. Regular physical activity – including football – is a good way to reduce the risk of dementia and conditions such as heart disease.

Electromagnetic ‘bathing cap’ shows promise in early Alzheimer’s disease trial

23 September 2019

Female research participant wearing the MemorEM electromagnetic skullcap

In a new study, researchers designed a bathing cap-style head device, called the MemorEM, which was used to deliver electromagnetic waves to the brain. The purpose of this was to try to dissolve what are known as oligomers – groups of abnormal proteins – as they were forming. There was some sign of improvements on tests of thinking and memory in most of the people taking part in the study. This is an experimental, early-stage study that looked primarily at safety, so it cannot tell us for sure if the treatment works.

Over 20,000 research participants recruited through Join Dementia Research

5 August 2019

Graphic showing three rows of people above the caption "Over 20,000 participants in studies"

We’re pleased to announce that over 20,000 study participants have been involved in vital research thanks to Join Dementia Research. We would like to sincerely thank all the volunteers, researchers, champions and partners who have given their time so far. If you haven’t already, please sign up, and if you have, please help us spread the word so we can bring more volunteers and researchers together.

Healthy lifestyle reduces dementia risk even in those with genetic risk factors

22 July 2019

Fresh fruit on a platter

A new study suggests that regular exercise, not smoking, drinking sensibly, and eating a healthy diet have been found to reduce risk of getting dementia even if a person has a higher genetic risk of developing the condition. There are some limitations to the study, but overall the findings are good news. We cannot change our genetics, but this study suggests that regardless of this, changing our lifestyles could help everyone reduce their dementia risk.